Back

Alternative treatment to patients for whom drug eluting stent implantation is not indicated, thanks to drug eluting balloon:1 year clinical results of panelux study

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 4 - Mechanisms of restenosis - Its predictors and treatment PCI: primary PCI / patient subsets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Jerome Roncalli

Toulouse Rangueil University Hospital of Toulouse, Toulouse (France)

19 More presentations in this session

Presentation thumbnail
Predicting repeat revascularization after percutaneous coronary intervention: target lesion versus nontarget lesion revascularization
Professor S. Rha (Seoul, KR)
Presentation thumbnail
The impact of postprocedural trimetazidine therapy on bare metal stent restenosis in patients undergoing percutaneous coronary intervention
Professor U. Canpolat (Ankara, TR)
Abstract Slides
Presentation thumbnail
Comparison of acute and 1 year outcome of percutaneous coronary intervention for chronic total occlusion lesion between in stent occlusion and de novo lesion from the Japanese retrograde summit regist
Doctor S. Ebisawa (Toyohashi, JP)
Abstract
Presentation thumbnail
Anti-inflammatory treatment with colchicine to reduce in-stent neointima growth in patients with drug eluting stents
Associate Professor G. Giannopoulos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Comparison of drug-eluting balloon versus drug-eluting stent treatment of DES in-stent restenosis: a meta-analysis of randomized and observational studies
Professor G. Bajraktari (Pristina, XK)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Mechanisms of restenosis - Its predictors and treatment

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources